IP Library › Granted Patent US 11,673,968
Granted Patent B2
US 11,673,968 · App. 16/293,478 · Granted Jun 13, 2023

Anti-BRDU antibodies and methods of use

Inventors: Ulrich Brinkmann (Weilheim, DE); Guy Georges (Habach, DE); Johannes Auer (Schwaigen, DE); Wilma Lau (Munich, DE)
Assignee: Hoffmann-La Roche Inc.
C07K16/44A61K47/549A61K47/62A61K47/6803A61K47/6879C07K16/2881C07K2317/24C07K2317/31C07K2317/55C07K2317/622C07K2317/624
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,673,968
App. No.
16/293,478
Granted
Jun 13, 2023
Kind
B2
Abstract

The invention provides anti-BRDU antibodies and methods of using the same.

Claims (3)

1. A humanized anti-BRDU antibody, wherein the antibody comprises a VH with the amino acid sequence of SEQ ID NO: 09 and a VL with the amino acid sequence of SEQ ID NO: 10.

2. A complex comprising the humanized anti-BRDU antibody according to claim 1 and a nucleic acid comprising BRDU.

3. A pharmaceutical formulation comprising the humanized anti-BRDU antibody according to claim 1 and a pharmaceutically acceptable carrier.

Priority Claims (1)
EP 14174043 · Jun 26, 2014 · regional
Continuity (3)
Continuation 15382329 · Dec 16, 2016
Continuation PCTEP2015064322 · Jun 25, 2015
Related Publication 20200002437A1 · Jan 2, 2020